期刊文献+

慢性乙型肝炎抗病毒药物治疗进展 被引量:2

下载PDF
导出
作者 季旻游
出处 《淮海医药》 2005年第2期171-172,共2页 Journal of Huaihai Medicine
  • 相关文献

参考文献13

  • 1Lau GK,Carman WF,Locarnini SA,et al.Treatment of chronic hepatitis B virus infection:an Asia-Pacific perspective[J].J Gastroenterol Hepatol,1999,14(1):3-12.
  • 2万谟彬.慢性乙型肝炎治疗的现状及前景——APDW2001年会见闻[J].中华传染病杂志,2002,20(1):57-60. 被引量:81
  • 3Greenberg HB,Pouard RB,Lutwick LI,et al.Effect of human leucocyte infection on hepatitis B virus infection in patient with chronic active hepatitis[J].N Engl J Med,1996,296:517.
  • 4Davis GL.Hepatitis B:diagnosis and treatment[J].South Med J,1997,90(9):866-871.
  • 5缪晓辉.合理应用α干扰素治疗慢性乙型肝炎——2002年α干扰素治疗慢性乙型肝炎专家研讨会会议纪要[J].中华传染病杂志,2002,20(5):322-323. 被引量:48
  • 6王耀宗.抗HBV、HCV感染的研究动态——第五十一届美国肝病学会年会相关内容概述[J].国外医学(流行病学.传染病学分册),2001,28(1):36-39. 被引量:4
  • 7Cammac Di Bona D,Schepis F,et al.Effect of peginterferon alfa2a on liver histology in chronic hepatitis C:a meta-analysis of individual patient data[J].Hepatology,2004,39(2):333-42.
  • 8Honkoop P,Man RA,Zondervan PE,et al.Histological improvment in patients with chronic hepatitis B virus infection treated with lamivudine[J].Liver,1997,17(2):103-106.
  • 9Schiff E,Cianciara J,Karayaicin S,et al.The international lamivudine investigator group,Durable HbeAg and HbsAg seroconversion after lamivudine for chronic hepatitis B[J].J Hepatol,2003,32:99.
  • 10Allwn MI,Deslauriers M,Andrews CW,et al.Identification and characterization of mulations in hepatitis B virus resistant to lamivudine.Lamivudine Clinical Investigation Group[J].Hepatology,1998,27:1670-1678.

二级参考文献10

  • 1Core Working Party For Asia-Pacific Consensus On Hepatitis B And C.Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region[].Journal of Gastroenterology.2000
  • 2Niederau C,Heintges T,Lange S,et al.Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B[].The New England Journal of Medicine.1996
  • 3Heathcote EJ,Jeffers L,Wright T,et al.Loss of serum HBV DNA and HBeAg and seroconversion following short-term ( 12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase Ⅱ studies ( abstr )[].Hepatology.1998
  • 4Pastore G,Santantonio T,Milella A,et al.Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: respones to a 6month course of lymphoblastoid interferon[].Journal of Hepatology.1992
  • 5Perrillo RP,Wright T,Rakela J,et al.A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B[].Hepatology.2001
  • 6Chien RN,Liao YF,Chen TC,et al.Efficacy of thymosinα1 in patients with chronic type B hepatitis: a randomized controlled trial[].Hepatology.1998
  • 7Chang TT,Lai CL,Liaw YF,et al.Incremental increases in HBeAg seroconversion and continued ALT normalization in Asian chronic HBV patients treated with lamivudine for four years(abstr)[].Antiviral Therapy.2000
  • 8Hadziyannis S,Bramou T,Makris A,et al.Interferon alfa-2b treatment lf HBeAg negative serum HBV DNA positive chronic active hepatitis B[].Journal of Hepatology.1990
  • 9Greenberg HB,Pollard RB,Lutwick LI,et al.Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis[].The New England Journal of Medicine.1976
  • 10Tassopoulos NC,Volpes R,Pastore G,et al.Efficacy of lamivudine in patients with hepatitis B e antigen-negative hepatitis B virus DNA-positive ( precore mutant) chronic hepatitis B[].Hepatology.1999

共引文献124

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部